Albofungin vesicle nanobombs trigger lysosomal disruption for self-enhanced pyroptosis and cGAS-STING pathway activation in glioblastoma immunotherapy
文献类型:期刊论文
| 作者 | Chen, Chen1,5; Tan, Shuai5; Zhu, Xiaojing5; Song, Zefeng4,5; Xing, Yutong1,3,5; Jin, Wenrui5; Xu, Jingyi1,3,5; Song, Siqi4,5; Geng, Haoran5; Chen, Xingyu2,5 |
| 刊名 | JOURNAL OF CONTROLLED RELEASE
![]() |
| 出版日期 | 2026-04-10 |
| 卷号 | 392页码:14 |
| 关键词 | Outer membrane vesicles Lysosomal disruption Pyroptosis cGAS-STING Immunotherapy |
| ISSN号 | 0168-3659 |
| DOI | 10.1016/j.jconrel.2026.114718 |
| 通讯作者 | Huang, Chunshuai(huangchunshuai@simm.ac.cn) ; Wu, Zhenyong(wuzhenyong@simm.ac.cn) |
| 英文摘要 | Glioblastoma (GBM) remains one of the most intractable malignancies owing to the dual challenges of the blood brain barrier (BBB) and profound immunosuppression. Here, we present a nanobomb (OMV-ApoE@ALF) that integrates heterologous production of the aromatic polyketide albofungin (ALF) with programmable outer membrane vesicles (OMVs) displaying ApoE peptides for GBM immunotherapy. OMV-ApoE@ALF efficiently crossed the BBB, accumulated in tumors, and functioned as a lysosomal nanobomb to boost pyroptosis and activate cGAS-STING pathway, thereby promoting dendritic cell maturation, T-cell infiltration, and durable antitumor immunity. Mechanistically, OMV-ApoE@ALF delivered ALF into lysosomes, inducing lysosomal disruption, reactive oxygen species (ROS) production, and subsequent mitochondrial damage. Crucially, this lysosomal rupture also suppressed protective autophagy of tumor cells themselves, thereby reinforcing the cascade activation between caspase-3/GSDME-dependent pyroptosis and cGAS-STING signaling pathway. This lysosomal disruption-nanobomb represents a new strategy for advancing GBM immunotherapy. |
| WOS关键词 | CLEAVAGE |
| 资助项目 | Key R & D Program of Shandong Province[2024CXPT029] ; Key R & D Program of Shandong Province[2025CXPT012] ; National Natural Science Foundation of China[32371283] ; National Natural Science Foundation of China[22407132] ; Taishan Scholars Program[2023000027] ; Taishan Scholars Program[tsqn202408316] ; Postdoctoral Fellowship Program of CPSF[GZC20241828] ; China Postdoctoral Science Foundation[2024M763416] ; Shandong Provincial Natural Science Fund for Excellent Young Scientists Fund Program (Overseas)[2025HWYQ-069] ; Shandong Provincial Natural Science Foundation[ZR2024QB342] ; Shandong Provincial Natural Science Foundation[ZR2024QC204] ; Shanghai Pujiang Program[23PJ1415100] ; Shandong Laboratory Program[SYS202205] ; Special Supporting Funds for Leading Talents at or Above the Provincial Level in Yantai City[2023000090] |
| WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:001693405100001 |
| 出版者 | ELSEVIER |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/323038] ![]() |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Huang, Chunshuai; Wu, Zhenyong |
| 作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 2.Jiangxi Normal Univ, Coll Life Sci, Nanchang 330022, Jiangxi, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 4.Dalian Univ Technol, Fac Med, Dalian 116024, Peoples R China 5.Bohai Rim Adv Res Inst Drug Discovery, Shandong Lab Yantai Drug Discovery, Yantai 264117, Shandong, Peoples R China |
| 推荐引用方式 GB/T 7714 | Chen, Chen,Tan, Shuai,Zhu, Xiaojing,et al. Albofungin vesicle nanobombs trigger lysosomal disruption for self-enhanced pyroptosis and cGAS-STING pathway activation in glioblastoma immunotherapy[J]. JOURNAL OF CONTROLLED RELEASE,2026,392:14. |
| APA | Chen, Chen.,Tan, Shuai.,Zhu, Xiaojing.,Song, Zefeng.,Xing, Yutong.,...&Wu, Zhenyong.(2026).Albofungin vesicle nanobombs trigger lysosomal disruption for self-enhanced pyroptosis and cGAS-STING pathway activation in glioblastoma immunotherapy.JOURNAL OF CONTROLLED RELEASE,392,14. |
| MLA | Chen, Chen,et al."Albofungin vesicle nanobombs trigger lysosomal disruption for self-enhanced pyroptosis and cGAS-STING pathway activation in glioblastoma immunotherapy".JOURNAL OF CONTROLLED RELEASE 392(2026):14. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

